N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide

C33H32N6O2 — CID 157337758

IUPACN-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide
SMILESCC#CC(=O)NC12CC3CC(C1)CC(c1nc(-c4ccc(C(=O)Cc5ccccn5)cc4)c4c(N)nccn14)(C3)C2
InChIInChI=1S/C33H32N6O2/c1-2-5-27(41)38-33-18-21-14-22(19-33)17-32(16-21,20-33)31-37-28(29-30(34)36-12-13-39(29)31)24-9-7-23(8-10-24)26(40)15-25-6-3-4-11-35-25/h3-4,6-13,21-22H,14-20H2,1H3,(H2,34,36)(H,38,41)
InChIKeyBGAPYPFXVUOTRL-UHFFFAOYSA-N
MW544.66 g/mol
LogP4.53
Rot. Bonds6

About N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide

N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide (PubChem CID 157337758) has the molecular formula C33H32N6O2 and a molecular weight of 544.66 g/mol. Its IUPAC name is N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide.

Molecular Properties

Compound NameN-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide
PubChem CID157337758
Molecular FormulaC33H32N6O2
Molecular Weight544.66 g/mol
Exact Mass544.26
IUPAC NameN-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide
SMILESCC#CC(=O)NC12CC3CC(C1)CC(c1nc(-c4ccc(C(=O)Cc5ccccn5)cc4)c4c(N)nccn14)(C3)C2
InChIInChI=1S/C33H32N6O2/c1-2-5-27(41)38-33-18-21-14-22(19-33)17-32(16-21,20-33)31-37-28(29-30(34)36-12-13-39(29)31)24-9-7-23(8-10-24)26(40)15-25-6-3-4-11-35-25/h3-4,6-13,21-22H,14-20H2,1H3,(H2,34,36)(H,38,41)
InChIKeyBGAPYPFXVUOTRL-UHFFFAOYSA-N
XLogP4.53
TPSA115.27 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500544.66
LogP ≤ 54.53
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide?
The IUPAC name of N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide (CID 157337758) is N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide.
What is the SMILES notation for N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide?
The canonical SMILES for N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide is CC#CC(=O)NC12CC3CC(C1)CC(c1nc(-c4ccc(C(=O)Cc5ccccn5)cc4)c4c(N)nccn14)(C3)C2.
What is the InChIKey of N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide?
The InChIKey is BGAPYPFXVUOTRL-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H32N6O2/c1-2-5-27(41)38-33-18-21-14-22(19-33)17-32(16-21,20-33)31-37-28(29-30(34)36-12-13-39(29)31)24-9-7-23(8-10-24)26(40)15-25-6-3-4-11-35-25/h3-4,6-13,21-22H,14-20H2,1H3,(H2,34,36)(H,38,41).
What are the key properties of N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide?
N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide has a molecular weight of 544.66 g/mol, XLogP of 4.53, 6 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[8-amino-1-[4-(2-pyridin-2-ylacetyl)phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-adamantyl]but-2-ynamide is sourced from PubChem (CID 157337758), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).